OUR PLATFORM | APPLICATIONS

Architects of Animal Health

Designed to support more efficient healing in animals large and small.
In animal health, trauma, surgical intervention and complex wounds can disrupt the extracellular matrix (ECM) and compromise the biological foundation healing depends on. When that scaffold is lost, tissue repair becomes less organized, and regeneration becomes harder to support. Yet many current approaches still focus on coverage rather than rebuilding the structural foundation needed for regeneration.
This is the unmet need CXU is poised to address.

Overview

Engineered to mimic the body’s natural extracellular matrix, our collagen-based ECM is designed to create a more complete structural environment than collagen alone. In oral care, CXU is being developed to help rebuild the soft-tissue architecture needed for healthy attachment, organized healing and regeneration. Designed to gel in place within approximately 10 minutes, it conforms naturally to the treatment site, fills irregular spaces and potentially supports cell infiltration and vascular ingrowth across periodontal and implant procedures.

CAUTION: CXU™ is a medical device candidate in preclinical development and is not cleared or approved for marketing in the United States or any other jurisdiction.

How CXU Works

How it works

The CXU formula creates a permissive and adaptive extracellular matrix environment, designed to conform, integrate and regenerate.9,3,6

Conform
  • Flows into irregular spaces
  • Maintains close tissue contact
  • Adapts to local tissue architecture
Integrate
  • Gels near body temperature
  • Forms within approximately 10 minutes
  • Stays in place without migration
Regenerate
  • Designed to support tissue restoration
  • Designed to mimic tissue ECM
  • Intended to support durable closure and regeneration with less scarring
CAUTION: CXU™ is a medical device candidate in preclinical development and is not cleared or approved for marketing in the United States or any other jurisdiction.

Key Features

When animal tissue is destroyed by trauma or chronic wound, CXU is designed to provide these benefits.*,1, 6, 9

Collagen-ECM Scaffold

Designed to more closely mimic the complexity of the body’s natural extracellular matrix, offering a more complete structurally supportive environment than collagen alone.

Tissue Integration

Engineered to confrom and support a faster path to closure, with potential to reduce time in advanced wound therapy.

Better Outcomes

Designed to potentially lower complication and risk associated with incomplete closures and non-integrated interfaces.

*Design intent based on preclinical evidence. These findings were generated in controlled laboratory settings and animal models. These findings may not be predictive of clinical performance or safety. Clinical significance not yet established.

Explore Other Applications

IMPORTANT NOTICES: CXU™ is a medical device candidate in preclinical development. It has not been submitted to or reviewed by the U.S. Food and Drug Administration. Safety and effectiveness have not been established. See Forward-Looking Cautionary Statement.Terms such as 'next-generation,' 'advanced,' 'innovative,' and 'bioregenerative' reflect the Company's assessment of its technology relative to existing approaches and are not intended as representations of regulatory status, clinical performance, or guaranteed commercial outcomes. CXU™ is an investigational medical device candidate. Safety and effectiveness have not been established. See Forward-Looking Cautionary Statement.
Close

Error Displaying Name

Error Displaying Title

Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage, and going through the cites of the word in classical literature, discovered the undoubtable source.Lorem Ipsum comes from sections 1.10.32 and 1.10.33 of "de Finibus Bonorum et Malorum" (The Extremes of Good and Evil) by Cicero, written in 45 BC. This book is a treatise on the theory of ethics, very popular during the Renaissance. The first line of Lorem Ipsum, "Lorem ipsum dolor sit amet..", comes from a line in section 1.10.32.The standard chunk of Lorem Ipsum used since the 1500s is reproduced below for those interested. Sections 1.10.32 and 1.10.33 from "de Finibus Bonorum et Malorum" by Cicero are also reproduced in their exact original form, accompanied by English versions from the 1914 translation by H. Rackham.